| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w23403 |
| 来源ID | Working Paper 23403 |
| Can at Scale Drug Provision Improve the Health of the Targeted in Sub-Saharan Africa? | |
| Adrienne M. Lucas; Nicholas L. Wilson | |
| 发表日期 | 2017-05-15 |
| 出版年 | 2017 |
| 语种 | 英语 |
| 摘要 | The single largest item in the United States foreign aid health budget is antiretroviral therapy (ART) for the treatment of HIV/AIDS. Many supply- and demand-side factors in sub-Saharan Africa could cause smaller than expected epidemiological effects of this at scale drug provision. We provide what appears to be the first quasi-experimental evidence on the effect of at scale drug provision in a poor country, using the phased roll-out of ART in Zambia, a setting where approximately 1 in 6 adults are HIV positive. Combining anthropometric data from national household surveys and a spatially-based triple difference specification, we find that local ART introduction increased the weight of high HIV likelihood adult women. This finding from a clinically difficult setting suggest that the generalized challenges of scalability of ART for adult health in sub-Saharan Africa are surmountable. |
| 主题 | Public Economics ; National Fiscal Issues ; Health, Education, and Welfare ; Health ; Development and Growth ; Development |
| URL | https://www.nber.org/papers/w23403 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/581077 |
| 推荐引用方式 GB/T 7714 | Adrienne M. Lucas,Nicholas L. Wilson. Can at Scale Drug Provision Improve the Health of the Targeted in Sub-Saharan Africa?. 2017. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
| w23403.pdf（914KB） | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
